LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 1 | I17 | 72 | hr | 1476 | 2526 | 3694 | 0.6838 | 0.4732 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 2 | I17 | 72 | hr | 1476 | 2764 | 3694 | 0.7482 | 0.5806 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 3 | I17 | 72 | hr | 1476 | 2759 | 3694 | 0.7469 | 0.5783 |
| SK-BR-3 | PLX-4720 | 0.12 | uM | LJP5 | 1 | K05 | 72 | hr | 1476 | 3691 | 3694 | 0.9992 | 0.9986 |
| SK-BR-3 | PLX-4720 | 0.12 | uM | LJP5 | 2 | K05 | 72 | hr | 1476 | 3546 | 3694 | 0.9599 | 0.9332 |
| SK-BR-3 | PLX-4720 | 0.12 | uM | LJP5 | 3 | K05 | 72 | hr | 1476 | 3939 | 3694 | 1.0663 | 1.1105 |
| SK-BR-3 | QL-X-138 | 0.12 | uM | LJP6 | 1 | F23 | 72 | hr | 1476 | 2019 | 3694 | 0.5466 | 0.2446 |
| SK-BR-3 | QL-X-138 | 0.12 | uM | LJP6 | 2 | F23 | 72 | hr | 1476 | 2202 | 3694 | 0.5961 | 0.3271 |
| SK-BR-3 | QL-X-138 | 0.12 | uM | LJP6 | 3 | F23 | 72 | hr | 1476 | 2153 | 3694 | 0.5828 | 0.3050 |
| SK-BR-3 | QL-XII-47 | 0.12 | uM | LJP6 | 1 | O23 | 72 | hr | 1476 | 2075 | 3694 | 0.5617 | 0.2698 |
| SK-BR-3 | QL-XII-47 | 0.12 | uM | LJP6 | 2 | O23 | 72 | hr | 1476 | 1928 | 3694 | 0.5219 | 0.2035 |
| SK-BR-3 | QL-XII-47 | 0.12 | uM | LJP6 | 3 | O23 | 72 | hr | 1476 | 1734 | 3694 | 0.4694 | 0.1160 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP5 | 1 | K11 | 72 | hr | 1476 | 1905 | 3694 | 0.5157 | 0.1932 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP5 | 2 | K11 | 72 | hr | 1476 | 1625 | 3694 | 0.4399 | 0.0669 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP5 | 3 | K11 | 72 | hr | 1476 | 1770 | 3694 | 0.4792 | 0.1323 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP6 | 1 | K11 | 72 | hr | 1476 | 1787 | 3694 | 0.4838 | 0.1399 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP6 | 2 | K11 | 72 | hr | 1476 | 1687 | 3694 | 0.4567 | 0.0948 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP6 | 3 | K11 | 72 | hr | 1476 | 1760 | 3694 | 0.4764 | 0.1278 |
| SK-BR-3 | Seliciclib | 0.12 | uM | LJP5 | 1 | J05 | 72 | hr | 1476 | 4148 | 3694 | 1.1229 | 1.2047 |
| SK-BR-3 | Seliciclib | 0.12 | uM | LJP5 | 2 | J05 | 72 | hr | 1476 | 3864 | 3694 | 1.0460 | 1.0766 |
| SK-BR-3 | Seliciclib | 0.12 | uM | LJP5 | 3 | J05 | 72 | hr | 1476 | 3993 | 3694 | 1.0809 | 1.1348 |
| SK-BR-3 | Ruxolitinib | 0.12 | uM | LJP5 | 1 | O17 | 72 | hr | 1476 | 2995 | 3694 | 0.8108 | 0.6847 |
| SK-BR-3 | Ruxolitinib | 0.12 | uM | LJP5 | 2 | O17 | 72 | hr | 1476 | 3487 | 3694 | 0.9440 | 0.9066 |
| SK-BR-3 | Ruxolitinib | 0.12 | uM | LJP5 | 3 | O17 | 72 | hr | 1476 | 3360 | 3694 | 0.9096 | 0.8494 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 1 | G11 | 72 | hr | 1476 | 4465 | 3694 | 1.2087 | 1.3477 |